Answer
Respreeza has not undergone animal reproduction studies or established pregnancy safety in controlled human trials; because alpha1-proteinase inhibitor is an endogenous human protein, fetal harm is considered unlikely at recommended doses, but use during pregnancy requires caution.
Sources for this answer
- RespreezaCSL Behring UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked